SULT1B1
Basic information
Region (hg38): 4:69721167-69787961
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULT1B1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 11 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 8 | 2 | 2 |
Variants in SULT1B1
This is a list of pathogenic ClinVar variants found in the SULT1B1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-69727102-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
4-69727131-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
4-69727141-T-C | not specified | Uncertain significance (Jan 19, 2024) | ||
4-69727143-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
4-69727197-G-A | Likely benign (Jan 01, 2023) | |||
4-69730614-T-C | not specified | Uncertain significance (Mar 16, 2022) | ||
4-69730651-T-C | not specified | Uncertain significance (Oct 20, 2021) | ||
4-69733441-A-T | not specified | Uncertain significance (May 22, 2023) | ||
4-69734207-A-C | Benign (Mar 30, 2018) | |||
4-69734248-C-G | not specified | Uncertain significance (Aug 15, 2023) | ||
4-69740308-A-G | Levothyroxine response | other (-) | ||
4-69749810-G-T | not specified | Uncertain significance (Mar 31, 2024) | ||
4-69749818-C-T | not specified | Uncertain significance (May 20, 2024) | ||
4-69754675-G-A | not specified | Likely benign (Jan 02, 2024) | ||
4-69754755-A-G | Benign (Jul 31, 2018) | |||
4-69755140-G-T | not specified | Uncertain significance (Apr 20, 2024) | ||
4-69755208-G-A | not specified | Uncertain significance (Mar 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SULT1B1 | protein_coding | protein_coding | ENST00000310613 | 7 | 66800 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.26e-8 | 0.327 | 125659 | 0 | 79 | 125738 | 0.000314 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.445 | 172 | 156 | 1.10 | 0.00000764 | 1980 |
Missense in Polyphen | 72 | 61.294 | 1.1747 | 747 | ||
Synonymous | -1.36 | 62 | 49.8 | 1.25 | 0.00000237 | 504 |
Loss of Function | 0.645 | 13 | 15.8 | 0.825 | 8.33e-7 | 194 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000725 | 0.000724 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000332 | 0.000326 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000300 | 0.000299 |
Middle Eastern | 0.000332 | 0.000326 |
South Asian | 0.000368 | 0.000359 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. Sulfonation increases the water solubility of most compounds, and therefore their renal excretion, but it can also result in bioactivation to form active metabolites. Sulfates dopamine, small phenols such as 1-naphthol and p-nitrophenol and thyroid hormones, including 3,3'-diiodothyronine, triidothyronine, reverse triiodothyronine and thyroxine. {ECO:0000269|PubMed:9443824, ECO:0000269|PubMed:9463486}.;
- Pathway
- Sulfation Biotransformation Reaction;Metapathway biotransformation Phase I and II;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;Cytosolic sulfonation of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.148
Intolerance Scores
- loftool
- 0.552
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.73
Haploinsufficiency Scores
- pHI
- 0.0599
- hipred
- N
- hipred_score
- 0.190
- ghis
- 0.486
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.700
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sult1b1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- ethanol catabolic process;cellular biogenic amine metabolic process;xenobiotic metabolic process;steroid metabolic process;flavonoid metabolic process;phenol-containing compound metabolic process;epithelial cell differentiation;thyroid hormone metabolic process;3'-phosphoadenosine 5'-phosphosulfate metabolic process;sulfation
- Cellular component
- cytosol
- Molecular function
- aryl sulfotransferase activity;protein binding;sulfotransferase activity